| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |